Key statistics
As of last trade AxoGen Inc (0HKD:LSE) traded at 30.66, -16.28% below its 52-week high of 36.62, set on Feb 03, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 30.66 |
| Low | 30.66 |
| Bid | -- |
| Offer | -- |
| Previous close | 30.66 |
| Average volume | 908.22 |
|---|---|
| Shares outstanding | 51.90m |
| Free float | 49.55m |
| P/E (TTM) | -- |
| Market cap | 1.59bn USD |
| EPS (TTM) | -0.3413 USD |
Data delayed at least 20 minutes, as of Mar 02 2026 19:04 GMT.
More ▼
Announcements
- Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
- Axogen Announces Proposed Public Offering of Common Stock
- Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
- Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
- Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Axogen, Inc. Reports Third Quarter 2025 Financial Results
More ▼
